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From 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies Vienna, Austria. 15-18 May 2011 Background Influenza, or "flu", is an upper respiratory tract infection caused by a virus belonging to the family of Orthomyxoviridae. Influenza can pose a serious risk to the health of mainly the elderly, the very young, and to people suffering from medical conditions (e.g. weak immune system). For example, seasonal influenza strains are fatal to more than 50,000 people annually in the United States alone [1] . The most effective measure for preventing influenzarelated morbidity and mortality is annual vaccination. Seasonal influenza vaccines are almost exclusively produced using the traditional egg-based manufacturing process. However, the main limitation of egg-based technology (especially in the case of a pandemic) is the time-consuming production process (~6 months). Furthermore, people with serious egg allergy cannot be vaccinated when trace amounts of egg protein remain in the final formulation. Therefore, new production processes using continuous cell lines for influenza vaccine manufacturing are currently being established [2] .
Influenza viruses take advantage of the host cell metabolism to replicate their genetic material and to synthesize viral proteins. The influenza virus particle consists of three major parts: the ribonucleocapsid, the matrix protein M1, and the envelope, which is derived from the plasma membrane of the host cell. The lipid bilayer contains the ion channel protein M2 and the immunogenic glycoproteins hemagglutinin and neuraminidase [3] . The replication cycle of influenza viruses including entry, uncoating, genome transcription and replication, assembly and release has been studied extensively with type A strains [4] . So far, only few studies have characterized the influence of influenza infection on the central carbon metabolism of host cells [5] . Madin-Darby canine kidney (MDCK) cells are considered a suitable substrate for cell culture-based influenza vaccine manufacturing [2, 6] . In this study, key metabolic enzyme activities were analyzed in MDCK cells infected with an influenza A virus strain to improve our understanding of virus-host cell interaction and cell response.
Materials and methods
All chemicals and enzymes were purchased from Sigma (Taufkirchen, Germany) or Roche (Mannheim, Germany). Adherent MDCK cells obtained from the ECACC (No. 84121903) were routinely cultured in 6-well plates containing 4 mL of GMEM-based medium (2 mM glutamine, 30 mM glucose, 10 % (v/v) fetal calf serum, 2 g/L peptone, 48 mM NaHCO 3 ) in a CO 2 incubator at 37°C and 5 % CO 2 to the stationary phase (~5 days of growth, 4.0-4.2 x 10 6 cells) [7] . Cell concentration and viability was determined for samples from 6-well plates as described previously [8] . MDCK cells were either mock-infected or infected with MDCK celladapted human influenza virus A/Puerto Rico/8/34 (H1N1) from the Robert Koch Institute (Berlin, Germany) at a multiplicity of infection of 20 as described previously [5, 9] . Cells were washed twice with ice-cold phosphate-buffered saline 9 hours post infection (hpi), and the complete plate was then snap-frozen in liquid nitrogen and stored at -80°C until further use. After thawing, samples were extracted by sonification on maximum power for 30 s with 1 mL extraction buffer [7] and kept at 0-4°C. To remove cell debris, samples were centrifuged at 16,000 x g for 5 min. The supernatant was used to measure the respective enzyme activities. The procedure for the enzyme activity analysis and the details for the specific assay mixes were as described previously [7] . 
Results
The maximum catalytic activities of 28 enzymes from central carbon metabolism were measured under substrate saturation using a recently developed assay platform for mammalian cells [7] . Table 1 enzyme from glutaminolysis, PC, citrate synthase, citrate lyase and NAD-ICDH from the citric acid cycle, and acetate-CoA-ligase ( Figure 1 ). The fact that maximum enzyme activities in H1N1 infected cells were always higher than in mock-infected cells suggests an up-regulation of metabolic activities during early virus replication.
Conclusions
In the present work, the effect of an influenza virus infection on host cell metabolism was investigated. Experimental data clearly suggests a change in metabolism of cells infected with human influenza A (H1N1), i. e. an up-regulation of key metabolic enzyme activities in MDCK cells. This shift in metabolism is most likely required to compensate for the metabolic imbalance caused by viral replication. Interestingly, activity of some key enzymes producing NADPH and acetyl-CoA, a precursor needed for lipid and cholesterol biosynthesis, were increased by at least 20 % in infected MDCK cells. Hence, fatty acid synthesis might play a crucial role for the replication of influenza viruses as they acquire lipid envelopes from their host cells. CS, citrate synthase; G6PDH, glucose-6-phosphate dehydrogenase; GLNase, glutaminase; MDH, malate dehydrogenase; ME, malic enzyme; PDH, pyruvate dehydrogenase; PC, pyruvate carboxylase.
